ACIP Updates MMR Vaccination Guidelines

The Advisory Committee on Immunization Practices (ACIP) has new guidelines for preventing measles, mumps, rubella, and congenital rubella syndrome.

The revisions include:

  • All patients aged 12 months and older with HIV infection who don't have severe immunosuppression should be vaccinated against measles, mumps, and rubella (MMR).
  • Patients with perinatal HIV who received their MMR vaccination before antiretroviral therapy began should be revaccinated with two doses.
  • The use of immune globulin administered intramuscularly (IGIM) is recommended for infants from birth to 6 months who've been exposed to measles. In immunocompetent patients, the recommended dose of IGIM has increased.
  • Intravenous immune globulin is recommended for severely immunocompromised people and for pregnant women who have been exposed to measles but who don't have evidence of immunity.

August is National Immunization Awareness Month, a great time for a TMA Be Wise — ImmunizeSM vaccination or educational event. You can help kids prepare to head back to school or college with a shot clinic. Or educate families that vaccinations are important, safe, and effective – and needed across the lifespan.  

Start planning your back-to-school Be Wise — Immunize event. Check out the new Be Wise Quick Start Manual for step-by-step tips to plan your event.  

Be Wise — Immunize is a service mark of the Texas Medical Association.

Action, July 1, 2013